The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation

Journal of Thrombosis and Haemostasis

Volumn 14, Issue 3, 2016, Pages 531-545

  Kozarcanin, H ^a   Lood, C ^b   Munthe Fog, L ^c   Sandholm, K ^d   Hamad, O A ^a   Bengtsson, A A ^b   Skjoedt, M O ^c   Huber Lang, M ^e   Garred, P ^c   Ekdahl, K N ^a,d   Nilsson, B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LINNAEUS UNIVERSITY   (Sweden)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Blood coagulation; Complement pathway; Fibrin; Mannose binding lectin; Mannose binding protein associated serine proteases; Platelet activation

Indexed keywords

ANTITHROMBIN; COMPLEMENT COMPONENT C1S INHIBITOR; FIBRIN; FICOLIN; HEPARIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG; MASP1 PROTEIN, HUMAN; MASP2 PROTEIN, HUMAN; PROTEIN BINDING;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME BINDING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MULTIPLE TRAUMA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOSIS; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; THROMBOCYTE; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN PROTEINS; BLOOD COAGULATION; BLOOD PLATELETS; CASE-CONTROL STUDIES; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; ENZYME ACTIVATION; FEMALE; FIBRIN; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; MULTIPLE TRAUMA; PLATELET ACTIVATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; THROMBOSIS; TIME FACTORS; YOUNG ADULT;

EID: 84960100143     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13208     Document Type: Article

References (39)

1. Garred P, Honore C, Ma YJ, Rorvig S, Cowland J, Borregaard N, Hummelshoj T. The genetics of ficolins. J Innate Immun 2010; 2: 3-16.
2. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7: 85-94.
3. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006; 68: 193-209.
4. Endo Y, Matsushita M, Fujita T. The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 2011; 43: 705-12..
5. Garred P, Borregaard N. The ficolins. J Innate Immun 2010; 2: 1-2.
6. Ma YJ, Skjoedt MO, Garred P. Collectin-11/MASP complex formation triggers activation of the lectin complement pathway-the fifth lectin pathway initiation complex. J Innate Immun 2013; 5: 242-50.
7. Schwaeble W, Dahl MR, Thiel S, Stover C, Jensenius JC. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiology 2002; 205: 455-66.
8. Skjoedt MO, Hummelshoj T, Palarasah Y, Honore C, Koch C, Skjodt K, Garred P. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J Biol Chem 2010; 285: 8234-43.
9. Skjoedt MO, Palarasah Y, Munthe-Fog L, Jie Ma Y, Weiss G, Skjodt K, Koch C, Garred P. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation. Immunobiology 2010; 215: 921-31.
10. Thiel S, Jensen L, Degn SE, Nielsen HJ, Gal P, Dobo J, Jensenius JC. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol 2012; 169: 38-48.
11. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386: 506-10.
12. Heja D, Kocsis A, Dobo J, Szilagyi K, Szasz R, Zavodszky P, Pal G, Gal P. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 2012; 109: 10498-503.
13. Pavlov VI, Skjoedt MO, Siow Tan Y, Rosbjerg A, Garred P, Stahl GL. Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis. Circulation 2012; 126: 2227-35.
14. Krarup A, Wallis R, Presanis JS, Gal P, Sim RB. Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS ONE 2007; 2: e623.
15. Dobo J, Major B, Kekesi KA, Szabo I, Megyeri M, Hajela K, Juhasz G, Zavodszky P, Gal P. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS ONE 2011; 6: e20036.
16. Hess K, Ajjan R, Phoenix F, Dobo J, Gal P, Schroeder V. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS ONE 2012; 7: e35690.
17. Krarup A, Gulla KC, Gal P, Hajela K, Sim RB. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim Biophys Acta 2008; 1784: 1294-300.
18. La Bonte LR, Pavlov VI, Tan YS, Takahashi K, Takahashi M, Banda NK, Zou C, Fujita T, Stahl GL. Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis. J Immunol 2012; 188: 885-91.
19. Jenny L, Dobo J, Gal P, Schroeder V. MASP-1 of the complement system promotes clotting via prothrombin activation. Mol Immunol 2015; 65: 398-405.
20. Parej K, Dobo J, Zavodszky P, Gal P. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while alpha2-macroglobulin is not. Mol Immunol 2013; 54: 415-22.
21. Gulati S, Sastry K, Jensenius JC, Rice PA, Ram S. Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin. J Immunol 2002; 168: 4078-86.
22. Bray B, Lane DA, Freyssinet JM, Pejler G, Lindahl U. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Biochem J 1989; 262: 225-32.
23. Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6: 98.
24. Speth C, Rambach G, Wurzner R, Lass-Florl C, Kozarcanin H, Hamad OA, Nilsson B, Ekdahl KN. Complement and platelets: mutual interference in the immune network. Mol Immunol 2015; 67: 108-18.
25. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 2007; 65: 383-92.
26. Munthe-Fog L, Hummelshoj T, Honore C, Moller ME, Skjoedt MO, Palsgaard I, Borregaard N, Madsen HO, Garred P. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun 2012; 13: 515-22.
27. Munthe-Fog L, Hummelshoj T, Ma YJ, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008; 45: 2660-6.
28. Back J, Lang MH, Elgue G, Kalbitz M, Sanchez J, Ekdahl KN, Nilsson B. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials 2009; 30: 6573-80.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
30. Back J, Lood C, Bengtsson AA, Ekdahl KN, Nilsson B. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus. Arthritis Res Ther 2013; 15: R206.
31. Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L, Sturfelt G, Erlinge D, Bengtsson AA. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 2010; 116: 1951-7.
32. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14: 187-96.
33. Hamad OA, Nilsson PH, Wouters D, Lambris JD, Ekdahl KN, Nilsson B. Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol 2010; 184: 2686-92.
34. Hein E, Honore C, Skjoedt MO, Munthe-Fog L, Hummelshoj T, Garred P. Functional analysis of Ficolin-3 mediated complement activation. PLoS ONE 2010; 5: e15443.
35. Hajela K, Kojima M, Ambrus G, Wong KH, Moffatt BE, Ferluga J, Hajela S, Gal P, Sim RB. The biological functions of MBL-associated serine proteases (MASPs). Immunobiology 2002; 205: 467-75.
36. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000; 165: 2637-42.
37. Endo Y, Nakazawa N, Iwaki D, Takahashi M, Matsushita M, Fujita T. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway. J Innate Immun 2010; 2: 33-42.
38. Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senecal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 2006; 15: 835-9.
39. Ekdahl KN, Nilsson B, Pekna M, Nilsson UR. Generation of iC3 at the interface between blood and gas. Scand J Immunol 1992; 35: 85-91.